Synergistic behavioral and neuroplastic effects of psilocybin-NMDAR modulator administration
Translational Psychiatry June 13, 2025 Tom Ben-Tal, Ilana Pogodin, Alexander Botvinnik et al. 2 citations
The full therapeutic potential of serotonergic psychedelics (SP) in treating neuropsychiatric disorders, such as depression and schizophrenia, is limited by possible adverse effects, including perceptual disturbances and psychosis, which require administration in controlled clinical environments. This study investigates the synergistic benefits of combining psilocybin (PSIL) with...